Internal Medicine · Marshfield, WI
NPI
1013323187
Since 2014
Specialty
Internal Medicine
Code 207R00000X
Group practices
7
Medicare group memberships
Hospitals
4
Hospital affiliations
1000 N Oak Ave
Marshfield, WI, 54449
Phone (715) 387-5511
Groups this clinician bills Medicare through
Medicare paid, 2024
$45K
700 services
Medicare patients, 2024
297
Average age 73
Drug cost, 2024
$1.1M
10,991 prescriptions
Company payments, 2025
$14.75
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James Nash was code 99214 (office e&m - established), 322 times for 233 patients. In total James Nash billed 700 services in 18 codes, and Medicare paid $45K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 322 | 233 | $58.97 | $19K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Facility | 130 | 130 | $122.04 | $16K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 102 | 84 | $12.04 | $1,228 |
| 99213 Office E&M - Established | Facility | 59 | 53 | $43.95 | $2,593 |
| 99215 Office E&M - Established | Facility | 50 | 38 | $89.96 | $4,498 |
By year: 2022 $131K for 5,033 services; 2023 $33K for 1,725 services; 2024 $45K for 700 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80053 Clinical Chemistry | 312 | 264 | $10.35 | $3,229 |
| 80061 Clinical Chemistry | 213 | 205 | $13.12 | $2,795 |
| 85025 Blood Count | 180 | 144 | $7.59 | $1,367 |
| 85610 Clinical Chemistry | 179 | 18 | $4.20 | $752 |
| 85027 Blood Count | 139 | 135 | $6.32 | $879 |
| 83036 Blood Count | 107 | 82 | $9.49 | $1,015 |
| 80048 Clinical Chemistry | 68 | 53 | $8.20 | $557 |
| 84443 Clinical Chemistry | 67 | 60 | $16.37 | $1,097 |
| G0103 Prostate cancer screening; prostate specific antigen test (psa) | 30 | 30 | $18.92 | $568 |
| 81001 Clinical Chemistry | 29 | 24 | $3.11 | $90.19 |
Medicare prescription drug claims, 2024
In 2024, the drug James Nash prescribed most often to Medicare patients was Atorvastatin Calcium, with 658 prescriptions and refills. In total James Nash wrote 10,991 Medicare prescriptions that cost $1.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 658 | 1,773 | 270 | $5,264 |
| Lisinopril Generic | 484 | 1,340 | 194 | $3,015 |
| Omeprazole Generic | 422 | 1,094 | 157 | $5,085 |
| Amlodipine Besylate Generic | 379 | 1,032 | 149 | $2,327 |
| Metoprolol Succinate Generic | 333 | 899 | 117 | $4,152 |
| Levothyroxine Sodium Generic | 315 | 815 | 122 | $3,244 |
| Metformin Hcl Generic | 291 | 762 | 103 | $2,512 |
| Gabapentin Generic | 289 | 574 | 84 | $4,518 |
| Losartan Potassium Generic | 279 | 793 | 117 | $2,311 |
| Hydrochlorothiazide Generic | 225 | 623 | 95 | $884 |
| Eliquis Apixaban | 190 | 377 | 58 | $211K |
| Simvastatin Generic | 185 | 493 | 64 | $1,400 |
| Tamsulosin Hcl Generic | 176 | 484 | 75 | $2,005 |
| Metoprolol Tartrate Generic | 170 | 465 | 67 | $1,086 |
| Warfarin Sodium Generic | 165 | 442 | 66 | $2,095 |
Brand drugs: 1,491 claims; generic drugs: 9,431 claims; opioid claims: 352.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James Nash $14.75 ($14.75 in general payments such as food, travel and fees) from 1 company. The largest payer was E.R. Squibb & Sons, L.L.C. with $14.75.
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $14.75 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.